Announcements Trials
Browse Landscape

Phase

Phase NA 70Phase 2 66Phase 1 20Phase 3 15Phase 1/2 10Phase EARLY_PHASE1 7Phase 4 2Phase 2/3 2

Status

Completed 32Recruiting 14Unknown 12Active not recruiting 7Terminated 6Withdrawn 2Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Colorectal Neoplasms 6Carcinoma, Hepatocellular 5Head and Neck Neoplasms 4Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms, Squamous Cell 2Glioblastoma 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Urinary Incontinence 1Tuberous Sclerosis 1Sarcoma 1Recurrent respiratory papillomatosis 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Postoperative Complications 1Papillomavirus Infections 1Papilloma 1Ovarian Neoplasms 1Orgasm 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Myasthenia Gravis 1Melanoma 1Medication Adherence 1

Interventions

Tacrolimus 1Sirolimus 1Cyclosporine 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Withdrawn × Prostatic Neoplasms × Clear all
NCT03800784 2021-12-15

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2/3 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT00922129 2014-01-14

Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer

St. Joseph's Healthcare Hamilton

Phase 2/3 Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡